APA

Boichard A., Croux L., Al Ghuzlan A., Broutin S., Dupuy C., Leboulleux S., Schlumberger M., Bidart J. M. & Lacroix L. (20121218). Somatic RAS mutations occur in a large proportion of sporadic RET-negative medullary thyroid carcinomas and extend to a previously unidentified exon. : The Journal of clinical endocrinology and metabolism.

Chicago

Boichard A, Croux L, Al Ghuzlan A, Broutin S, Dupuy C, Leboulleux S, Schlumberger M, Bidart J M and Lacroix L. 20121218. Somatic RAS mutations occur in a large proportion of sporadic RET-negative medullary thyroid carcinomas and extend to a previously unidentified exon. : The Journal of clinical endocrinology and metabolism.

Harvard

Boichard A., Croux L., Al Ghuzlan A., Broutin S., Dupuy C., Leboulleux S., Schlumberger M., Bidart J. M. and Lacroix L. (20121218). Somatic RAS mutations occur in a large proportion of sporadic RET-negative medullary thyroid carcinomas and extend to a previously unidentified exon. : The Journal of clinical endocrinology and metabolism.

MLA

Boichard A, Croux L, Al Ghuzlan A, Broutin S, Dupuy C, Leboulleux S, Schlumberger M, Bidart J M and Lacroix L. Somatic RAS mutations occur in a large proportion of sporadic RET-negative medullary thyroid carcinomas and extend to a previously unidentified exon. : The Journal of clinical endocrinology and metabolism. 20121218.